Rxsight Inc Quick Ratio (RXST) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Rxsight Inc   (NASDAQ: RXST)

Rxsight Inc 's Quick Ratio

RXST's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 5.03 below Rxsight Inc average.

Within Medical Equipment & Supplies industry 26 other companies have achieved higher Quick Ratio than Rxsight Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 497 to 805.

Explain Quick Ratio?
How much Cash & cash equivalents RXST´s has?
What are RXST´s Current Liabilities?




RXST Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 294.66 % 20.38 % -11.15 % -1.53 % 3.9 %
Y / Y Cash & cash equivalent Change 77.7 % -5 % -3.83 % -4.05 % -2.48 %
Quick Ratio MRQ 5.03 7.96 9.92 10.21 11.16
RXST's Total Ranking # 805 # 497 # 131 # 266 # 234
Seq. Current Liabilities Change 193.85 % 19.07 % 3.14 % 9.36 % -10.37 %
Seq. Cash & cash equivalent Change 85.54 % -4.49 % 0.27 % 0.01 % -0.81 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 302
Overall Market # 805


Quick Ratio Statistics
High Average Low
18.34 8.54 0.09
(Sep 30 2021)   (Dec 31 2022)




Financial Statements
Rxsight Inc 's Current Liabilities $ 80 Millions Visit RXST's Balance sheet
Rxsight Inc 's Cash & cash equivalent $ 404 Millions Visit RXST's Balance sheet
Source of RXST's Sales Visit RXST's Sales by Geography


Cumulative Rxsight Inc 's Quick Ratio

RXST's Quick Ratio for the trailling 12 Months

RXST Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 67.07 % 2.39 % 2.25 % 12.03 % 17.8 %
Y / Y Cash & cash equivalent TTM Growth 15.74 % -3.84 % 9.54 % 27.48 % 50.75 %
Quick Ratio TTM 7.04 9.68 10.32 10.09 10.16
Total Ranking TTM # 3838 # 1921 # 1479 # 2461 # 2538
Seq. Current Liabilities TTM Growth 64.55 % 5.24 % -3.16 % -0.38 % 0.84 %
Seq. Cash & cash equivalent TTM Growth 19.62 % -1.26 % -0.99 % -1.03 % -0.62 %


On the trailing twelve months basis Due to in Current Liabilities in the Q2 2026 to $80.44 millions, cumulative Quick Ratio decreased to 7.04 above the RXST average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Rxsight Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 1921 to 3838.

Explain Quick Ratio?
How much Cash & cash equivalents RXST´s has?
What are RXST´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 201
Healthcare Sector # 885
Within the Market # 3838


trailing twelve months Quick Ratio Statistics
High Average Low
3.77 1.44 0.55
(Mar 31 2022)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Ceribell Inc   13.13 $ 225.898  Millions$ 17.200  Millions
Perspective Therapeutics Inc   12.80 $ 467.708  Millions$ 36.544  Millions
Lemaitre Vascular Inc   12.57 $ 376.240  Millions$ 29.935  Millions
Mobia Medical Inc   12.24 $ 177.090  Millions$ 14.472  Millions
Envveno Medical Corporation  11.39 $ 21.486  Millions$ 1.887  Millions
Pulse Biosciences Inc   9.26 $ 101.620  Millions$ 10.978  Millions
Orchestra Biomed Holdings Inc   8.16 $ 109.963  Millions$ 13.471  Millions
Biolife Solutions Inc   8.11 $ 113.100  Millions$ 13.947  Millions
Bone Biologics Corporation  7.87 $ 4.032  Millions$ 0.512  Millions
Beyond Air Inc   7.68 $ 26.340  Millions$ 3.428  Millions
Talkspace Inc   7.62 $ 90.998  Millions$ 11.937  Millions
Safe Pro Group Inc   7.24 $ 10.231  Millions$ 1.413  Millions
Delcath Systems Inc   7.22 $ 95.902  Millions$ 13.279  Millions
Streamex Corp   7.16 $ 18.586  Millions$ 2.595  Millions
Endra Life Sciences Inc  7.04 $ 5.540  Millions$ 0.787  Millions
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions

Date modified: 2026-09-11T09:46:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.